Literature DB >> 12948108

The role of factor V Leiden mutation in recurrent pregnancy loss.

Jane Cleary-Goldman1, Gary S Nakhuda, Ralf C Zimmermann, Mark V Sauer.   

Abstract

Although recurrent pregnancy loss is rare, it is a major health problem. Fewer than 50% of cases have definitive causes. Thrombophilias such as factor V Leiden mutation may be responsible for a portion of the unexplained cases. In recent years, a number of studies have reached conflicting conclusions about the role of factor V Leiden in recurrent pregnancy loss. This article reviews the current literature. It appears that factor V Leiden mutation may be associated with stillbirth as well as with some poor pregnancy outcomes. The mutation may also be linked to first-trimester loss. Prospective case-controlled studies to better answer many of the questions concerning the role of this mutation in recurrent pregnancy loss and to determine optimal treatment may not be feasible because it is so rare. At this point, treatment involves anticoagulation and is based on observational studies and expert opinion.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12948108

Source DB:  PubMed          Journal:  J Am Med Womens Assoc (1972)        ISSN: 0098-8421


  2 in total

1.  The association between thrombophilic gene mutations and recurrent pregnancy loss.

Authors:  Ahmad Poursadegh Zonouzi; Nader Chaparzadeh; Saeid Ghorbian; Mahzad Mehrzad Sadaghiani; Laya Farzadi; Alieh Ghasemzadeh; Taiebeh Kafshdooz; Masoud Sakhinia; Ebrahim Sakhinia
Journal:  J Assist Reprod Genet       Date:  2013-08-29       Impact factor: 3.412

2.  High prevalence of three prothrombotic polymorphisms among Palestinians: factor V G1691A, factor II G20210A and methylenetetrahydrofolate reductase C677T.

Authors:  Ayman S Hussein
Journal:  J Thromb Thrombolysis       Date:  2012-10       Impact factor: 2.300

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.